Acinetobacter baumannii is increasingly refractory to antibiotic treatment in healthcare
settings. As is true of most human pathogens, the genetic path to antimicrobial resistance …

A unique, protective cell envelope contributes to the broad drug resistance of the
nosocomial pathogen Acinetobacter baumannii. Here we use transposon insertion …

Clin Microbiol Infect 2012; 18: E1–E4 Abstract Limited data on relative fitness and virulence
of antimicrobial‐resistant Acinetobacter baumannii are known. We aimed to study the …

Antibiotic-resistant infections lead to 700,000 deaths per year worldwide. The roles of
phenotypically diverse subpopulations of clonal bacteria in the progression of diseases are …

Antibiotic resistance is a growing global concern in the field of medicine as it renders
bacterial infections difficult to treat and often more severe. Acinetobacter baumannii is a …

Background Limited treatment options are available for patients infected with multidrug
(MDR)-or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can …

The emergence of fluoroquinolone resistance in nosocomial pathogens has restricted the
clinical efficacy of this antibiotic class. In Acinetobacter baumannii, the majority of clinical …

The ecological and evolutionary mechanisms of antimicrobial resistance (AMR) emergence
within patients and how these vary across bacterial infections are poorly understood …

The increasing antibiotic resistance of Acinetobacter species in both natural and hospital
environments has become a serious problem worldwide in recent decades. Because of both …

The opportunistic pathogen Acinetobacter baumannii, carries variants of A. baumannii
resistance islands (AbaR)-type genomic islands conferring multidrug resistance. Their …